Victoza is a brand-name diabetes medication manufactured by Novo Nordisk. It is approved by the U.S. Food and Drug Administration (FDA) along with a low-calorie diet and exercise to improve glycemic control in patients 10 years of age and older with T2DM.
Xeljanz was approved by the U.S. Food and Drug Administration (FDA) in late 2012 to treat rheumatoid arthritis. Since it has been on the market, Pfizer has raised Xeljanz’s price with it hitting its highest price in 2017.
Your body’s immune system helps fight off infections that cause illness. Sometimes it can mistakenly attack some healthy cells and tissues. Immunosuppressants help stop your immune system from causing damage to these cells and tissues.
Xeljanz is an oral medication used to help decrease the tenderness, swelling, and joint pain for people with certain types of arthritis. It is also used to reduce the symptoms of ulcerative colitis, including diarrhea, rectal bleeding, and abdominal pain.
Ozempic is a once-weekly injection used along with diet and exercise to treat adults with type 2 diabetes (T2DM). There have been shortages of Ozempic since early 2022 due to its off-label use as a weight loss drug.